ATE123815T1 - Spezifische bindende wirkstoffe. - Google Patents

Spezifische bindende wirkstoffe.

Info

Publication number
ATE123815T1
ATE123815T1 AT90312407T AT90312407T ATE123815T1 AT E123815 T1 ATE123815 T1 AT E123815T1 AT 90312407 T AT90312407 T AT 90312407T AT 90312407 T AT90312407 T AT 90312407T AT E123815 T1 ATE123815 T1 AT E123815T1
Authority
AT
Austria
Prior art keywords
human antibody
reshaped
specific binding
plap
binding ingredients
Prior art date
Application number
AT90312407T
Other languages
English (en)
Inventor
Martine Elisa Verhoeyen
Original Assignee
Unilever Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898926045A external-priority patent/GB8926045D0/en
Priority claimed from GB909019552A external-priority patent/GB9019552D0/en
Application filed by Unilever Nv filed Critical Unilever Nv
Application granted granted Critical
Publication of ATE123815T1 publication Critical patent/ATE123815T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Fireproofing Substances (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Dental Preparations (AREA)
  • Paper (AREA)
AT90312407T 1989-11-17 1990-11-14 Spezifische bindende wirkstoffe. ATE123815T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898926045A GB8926045D0 (en) 1989-11-17 1989-11-17 Specific binding agents
GB909019552A GB9019552D0 (en) 1990-09-07 1990-09-07 Specific binding agents

Publications (1)

Publication Number Publication Date
ATE123815T1 true ATE123815T1 (de) 1995-06-15

Family

ID=26296218

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90312407T ATE123815T1 (de) 1989-11-17 1990-11-14 Spezifische bindende wirkstoffe.

Country Status (16)

Country Link
EP (1) EP0429242B1 (de)
JP (1) JPH05501357A (de)
KR (2) KR970007783B1 (de)
AT (1) ATE123815T1 (de)
AU (1) AU652923B2 (de)
BG (1) BG60687B1 (de)
CA (1) CA2066670A1 (de)
DE (1) DE69020112T2 (de)
DK (1) DK0429242T3 (de)
ES (1) ES2075169T3 (de)
FI (1) FI922220A7 (de)
GR (1) GR3017407T3 (de)
HU (1) HUT64600A (de)
NO (2) NO303066B1 (de)
RO (1) RO110262B1 (de)
WO (1) WO1991007500A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9019553D0 (en) * 1990-09-07 1990-10-24 Unilever Plc Specific binding agents
EP1400536A1 (de) 1991-06-14 2004-03-24 Genentech Inc. Verfahren zur Herstellung humanisierter Antikörper
US6800738B1 (en) 1991-06-14 2004-10-05 Genentech, Inc. Method for making humanized antibodies
WO1994004679A1 (en) * 1991-06-14 1994-03-03 Genentech, Inc. Method for making humanized antibodies
GB0510790D0 (en) 2005-05-26 2005-06-29 Syngenta Crop Protection Ag Anti-CD16 binding molecules
JP5297742B2 (ja) * 2008-09-26 2013-09-25 株式会社青木科学研究所 金型用粉体含有油性潤滑剤、これを用いた静電塗布方法、及び静電塗布装置
SI3383920T1 (sl) 2015-11-30 2024-06-28 The Regents Of The University Of California Dostava tumorsko specifičnega koristnega tovora in imunska aktivacija z uporabo humanega protitelesa, ki cilja visoko specifičen površinski antigen tumorskih celic
CN112601546B (zh) * 2018-06-12 2024-04-16 湖南远泰生物技术有限公司 Plap-car-效应细胞
JP2024503933A (ja) 2021-01-27 2024-01-29 イノベント バイオロジクス（スーチョウ）カンパニー，リミティド Ｃｄ１６ａに対する単一ドメイン抗体およびその使用
JP2024537991A (ja) 2021-10-14 2024-10-18 アーセナル バイオサイエンシズ インコーポレイテッド 共発現されるｓｈＲＮＡと論理ゲートシステムとを有する免疫細胞
CN114014933B (zh) * 2021-11-17 2023-05-02 福州迈新生物技术开发有限公司 抗plap蛋白单克隆抗体、细胞系及其制备方法和应用
CN121773140A (zh) * 2023-08-25 2026-03-31 泰诚思生物医药私人有限公司 抗alpp/alppl2抗体、抗体-药物偶联物及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607679D0 (en) * 1986-03-27 1986-04-30 Winter G P Recombinant dna product

Also Published As

Publication number Publication date
HUT64600A (en) 1994-01-28
NO303066B1 (no) 1998-05-25
FI922220L (fi) 1992-05-15
DE69020112T2 (de) 1995-11-02
NO980656L (no) 1992-05-15
GR3017407T3 (en) 1995-12-31
WO1991007500A1 (en) 1991-05-30
EP0429242A2 (de) 1991-05-29
ES2075169T3 (es) 1995-10-01
EP0429242B1 (de) 1995-06-14
AU6736990A (en) 1991-06-13
KR970007783B1 (ko) 1997-05-16
DK0429242T3 (da) 1995-10-16
FI922220A0 (fi) 1992-05-15
DE69020112D1 (de) 1995-07-20
CA2066670A1 (en) 1991-05-18
RO110262B1 (ro) 1995-11-30
JPH05501357A (ja) 1993-03-18
KR970007782B1 (ko) 1997-05-16
NO921941D0 (no) 1992-05-15
BG60687B1 (bg) 1995-12-29
HU9201619D0 (en) 1992-08-28
AU652923B2 (en) 1994-09-15
BG96346A (bg) 1993-12-24
EP0429242A3 (de) 1991-06-05
FI922220A7 (fi) 1992-05-15
NO980656D0 (no) 1998-02-16
NO921941L (no) 1992-05-15
KR920703837A (ko) 1992-12-18

Similar Documents

Publication Publication Date Title
ATE233279T1 (de) Spezifisch bindende agentien
ATE123815T1 (de) Spezifische bindende wirkstoffe.
DE69633717D1 (de) Monoklonale anti-cd6 antikörper zur behandlung und diagnose von psoriasis
PT99934A (pt) Processo para a producao de um anticorpo anti-htnf alfa recombinante ou humanizado
DK153954C (da) Fremgangsmaade til fremstilling af et monoklonalt antistof, hybridomacellelinie til anvendelse ved fremgangsmaaden samt fremgangsmaade til diagnose og diagnostisk praeparat med det fremstillede monoklonale antistof
ATE114189T1 (de) Humane-humane hybridomas für neoplasmen.
NZ217829A (en) Monoclonal anti-human breast cancer antibodies and test reagent
NZ337072A (en) use of an anti-CD40L compounds to inhibit the progression of nephritis, stabilize nephritis or reverse nephritis in a patient with an immune complex disease
DK153891C (da) Fremgangsmaade til fremstilling af et monoklonalt antistof, hybridomacellelinie til anvendelse ved fremgangsmaaden samt fremgangsmaade til diagnose og diagnostisk praeparat med det fremstillede monoklonale antistof
DK0687295T3 (da) Human B-lymfoblastoidcellelinje, der secernerer anti-gangliosid-antistof
IT8124862A0 (it) Produzione di anticorpi monoclonali umani mediante ibridomi umani.
BG99074A (bg) Рекомбинантни човешки нiv-неутрализиращи моноклонални антитела за профилактика и лечение на нiv инфекция
ATE125870T1 (de) Hiv-spezifische monoklonale antikörper und hybridome zu ihrer herstellung.
NO174110C (no) Monoklonalt antistoff til anvendelse in vitro for diagnose av maligne tumor- eller akutte inflammasjonssykdommer, og som er spesifikt for N-acetyl-neuraminsyre i hybridom som produserer antistoffet
FI902735A7 (fi) Monoklonaalinen vasta-aine, joka reagoi tiettyyn laajasti erilaisissa ihmisleukemia- ja lymfomasoluissa esiintyvään antigeeniin ja menetelmä sen käyttämiseksi diagnoosiin ja hoitoon
DE3580524D1 (de) Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen.
KR970073606A (ko) 항 인체 인터루킨-6 항체 및 이를 이용한 인체 인터루킨-6의 검정
CA2141025A1 (en) Anti-mucus glycoprotein monoclonal antibody
EP0207170A4 (de) Verfahren zur herstellung menschlicher krebsspezifischer monoklonaler antikörper.
EP0089771A3 (de) ATCC HB 8116 und sein monoklonaler anti-h-y Antikörper, hyklonalan
FR2697088B1 (fr) Anticorps monoclonaux pour le diagnostic différentiel de cancers épithéliaux dans des épanchements séreux, hybridomes les secrétant et kit de diagnostic.
RU93058456A (ru) Антитела, способы диагностики, способ лечения, фармацевтическая композиция, клеточные линии
DK182188A (da) Humant tumorassocieret antigen
DK1414859T5 (da) Monoklonale anti-SSRP-1-antistoffer og hybridomer som producerer antistofferne

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee